Diagnostic Utility of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Infectious Diseases: A Retrospective Study

This study aims to evaluate the utility of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) test for various infectious indications, analyze its diagnostic value, and assess its correlation with suspected diagnoses. Additionally, secondary endpoints in...

Descripción completa

Detalles Bibliográficos
Autores: García-Zaragoza, Tania, Jover Diaz, Francisco, Peris García, Juan Jorge, Delgado Sánchez, Elisabet, Verdú-Rico, José, Lumbreras, Blanca
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad Miguel Hernández de Elche
Repositorio:REDIUMH. Depósito Digital de la UMH
OAI Identifier:oai:dspace.umh.es:11000/39353
Acceso en línea:https://hdl.handle.net/11000/39353
Access Level:acceso abierto
Palabra clave:18f-fdg pet/ct
bacteremia
diagnostic confirmation
fever of unknown origin
Descripción
Sumario:This study aims to evaluate the utility of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) test for various infectious indications, analyze its diagnostic value, and assess its correlation with suspected diagnoses. Additionally, secondary endpoints include evaluating the test's usefulness in clinical management and identifying predictors of PET/CT positivity. Methods: A retrospective descriptive observational study was conducted on in-hospital patients who underwent 18F-FDG PET/CT for suspected infections. Results: A total of 89 patients were reviewed. The predominant symptoms were fever (68.5%) and respiratory symptoms (38.2%). The most common prior complementary tests were microbiological (89.9%) and imaging (94.4%). Indications for PET/CT included fever of unknown origin (27%), focal infections (20.2%), bacteremia (34.8%), and immunocompromised patients (18%). Diagnostic confirmation was achieved in 60.7% of cases. The test's usefulness (confirmation and unexpected findings) was 76.4%. Only 9.5% of patients without an initial diagnosis after PET/CT received a confirmatory diagnosis later. The subgroup analysis revealed that fever of unknown origin was associated with a lower probability of confirmation and usefulness, whereas focal infection was linked to a higher likelihood of diagnostic confirmation. However, these associations did not persist in multivariate analysis due to the limited sample size. Conclusion: Our study aims to optimize the diagnostic profitability of the 18F-FDG PET/CT test for specific infectious disease indications by analyzing previous literature. In our experience, the PET/CT test demonstrated a high percentage of diagnostic confirmation for patients with focal infections. In contrast, its diagnostic yield was significantly lower for prolonged fever of unknown origin.